IceCure Medical (ICCM) Free Cash Flow (2020 - 2026)

IceCure Medical (ICCM) has reported Free Cash Flow for 7 consecutive years, with -$3.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 38.6% year-over-year to -$3.9 million in Q2 2026; TTM through Jun 2026 was -$15.8 million, a 11.82% decrease from a year earlier, with the FY2025 full-year figure at -$14.5 million, down 16.38% from the prior year.
• Free Cash Flow was -$3.9 million for Q2 2026 at IceCure Medical, up from -$4.2 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$2.2 million in Q4 2023 and troughed at -$5.0 million in Q4 2025.
• A 5-year average of -$3.4 million and a median of -$3.2 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow sank 123.12% in 2022 and jumped 44.81% in 2023, its largest moves.
• Over 5 years, Free Cash Flow stood at -$4.0 million in 2022, then surged by 44.81% to -$2.2 million in 2023, then sank by 88.48% to -$4.2 million in 2024, then fell by 19.67% to -$5.0 million in 2025, then gained by 22.88% to -$3.9 million in 2026.
• The last three Free Cash Flow figures came in at -$3.9 million (Q2 2026), -$4.2 million (Q1 2026), and -$5.0 million (Q4 2025), per Business Quant data.